David Kimber

Regional Director, Oncology Sales
Gilead Sciences

David joined Gilead in April of 2020, as the Regional Director for the Inflammation franchise expansion. In October of 2020, David moved over to support the HCV Business Unit in Chicago as a Regional Director where he worked on several area and national marketing projects and was selected to be on the National POA planning committee. In January of 2022, David was promoted to lead to Oncology sales team in the Northeast where he has built a new sales team promoting Trodelvy for metastatic Triple Negative Breast Cancer and metastatic Urothelial Carcinoma.